ClinicalTrials.Veeva

Menu

Plasma Levels of Danger-Associated Molecular Patterns in Young Children After Cardiac Surgery Under Cardiopulmonary Bypass (IMMUNOPED2)

N

Nantes University Hospital (NUH)

Status

Completed

Conditions

Cardiac Surgical Procedure

Treatments

Diagnostic Test: Blood drop sampling

Study type

Observational

Funder types

Other

Identifiers

NCT04423523
RC19_0402

Details and patient eligibility

About

The investigators have previously reported that cardiac surgery with cardiopulmonary bypass (CPB) in young infants induced a drastic reduction in mHLA-DR (Human Leucocyte Antigen) expression, which represents one of innate immune mediator. Danger-Associated Molecular Patterns (DAMPs) can elicit immune response and may subsequently induce an immune-suppressed state. We hypothesize that analyzing the proteomic and the whole blood transcriptomic response after cardiac surgery would provide new insights into the pathophysiological mechanisms of CPB-related inflammatory response.

Full description

Plasma levels of heat shock protein and inflammatory-related proteins will be measured at four time points (prior to the onset of surgery, Hour 6 postoperative, day 1 and day 3 after surgery). Whole blood transcriptomic analysis will be performed before and after surgery. The immune suppression induced by CPB will be assessed by in vitro experiments.

Enrollment

88 patients

Sex

All

Ages

Under 3 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient admitted to pediatric intensive care at Nantes University Hospital after cardiac surgery
  • Age ≤ 3 months corrected age.
  • Control group: patients less than 3 months old following cardiac surgery without CPB or digestive surgery with a central venous catheter.

Exclusion criteria

  • Futility of care with cessation of blood tests as part of a limitation of active therapies;
  • Absence of parents for information
  • Refusal of parents after information (Lack of parental consent)
  • Blood volume collected for medical purposes incompatible with the needs of the research.

Trial design

88 participants in 2 patient groups

Study population
Description:
The study population must correspond to the research inclusion criteria: Patient admitted to pediatric intensive care at Nantes University Hospital after cardiac surgery on bypass grafts
Treatment:
Diagnostic Test: Blood drop sampling
Control group
Description:
Infants under 3 months of age undergoing heavy digestive surgery and having a central venous catheter to facilitate access to blood samples.
Treatment:
Diagnostic Test: Blood drop sampling

Trial contacts and locations

1

Loading...

Central trial contact

Anne Chauvire-Drouard; Alexis Chenouard, ph

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems